Shinpoong Pharmaceutical (019170.KS) Earnings Analysis

Shinpoong Pharmaceutical (019170.KS) has no confirmed upcoming earnings date. Trailing P/E 39.37.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 019170.KS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 019170.KS. This page updates as the calendar is published.

019170.KS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-209 KRWn/an/an/a
2025-11-12124 KRWn/an/an/a
2025-08-1863.78 KRWn/an/an/a
2025-05-15-26.00012 KRWn/an/an/a
2025-02-21-246.54748 KRWn/an/an/a
2024-11-14-10.00004 KRWn/an/an/a
2024-08-14-1.02859 KRWn/an/an/a

019170.KS valuation and analyst view

Trailing P/E39.37
Trailing EPS194.94 KRW
Price / book1.46
Dividend yield0.00%
Market cap393.50B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Shinpoong Pharmaceutical (019170.KS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 019170.KS. This page updates as the calendar is published.

Did 019170.KS beat earnings last quarter?

Consensus estimate data was not available for 019170.KS's 2026-02-20 report.

What is 019170.KS's current P/E ratio and EPS?

019170.KS trades at a trailing P/E of 39.37 on trailing EPS of 194.93557413840696 KRW.

What do analysts rate 019170.KS?

019170.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.